JNK initiates Beclin-1 dependent autophagic cell death against Akt activation

Chao Zeng1, Zhixuan Zhang2, Wei Luo3

  • 1Department of Gastroenterology, The Third People's Hospital of Chengdu, Chengdu, 610031, PR China.

Insights

ABT-199 triggers autophagic cell death in cancer cells lacking Bax and Bak proteins. This process involves the JNK-Akt-14-3-3 pathway and Beclin-1, suggesting potential applications for ABT-199 in apoptosis-resistant solid tumors.

Area of Science:

  • Cellular biology
  • Molecular oncology
  • Cancer research

Background:

  • ABT-199 (Venetoclax) is a selective BCL-2 inhibitor primarily investigated for hematological malignancies.
  • Its role in solid tumors, especially those with impaired apoptosis, remains less explored.
  • Understanding alternative cell death pathways induced by ABT-199 is crucial for expanding its therapeutic potential.

Purpose of the Study:

  • To investigate the mechanism of ABT-199-induced cell death in the absence of Bax and Bak.
  • To elucidate the role of autophagy in ABT-199 treatment in apoptosis-deficient cells.
  • To identify the signaling pathways mediating ABT-199's effects.

Main Methods:

  • Utilized Bax/Bak double knockout (KO) and knockdown (KD) cell models.
  • Analyzed ABT-199's effect on autophagy and cell death.
  • Investigated the involvement of Beclin-1, Akt, and JNK signaling pathways through phosphorylation and protein interaction studies.

Main Results:

  • ABT-199 induced Beclin-1-dependent autophagic cell death independently of Bax and Bak.
  • Inactivated Akt released Beclin-1 from 14-3-3 protein via altered Beclin-1 phosphorylation.
  • JNK activation antagonized Akt by phosphorylating 14-3-3, reducing its interaction with Beclin-1, thus activating autophagy.

Conclusions:

  • ABT-199 activates the JNK-Akt-14-3-3 signaling pathway to induce Beclin-1-dependent autophagic cell death in Bax/Bak deficient cells.
  • This mechanism highlights a novel route for cancer cell death.
  • Findings suggest ABT-199 could be a viable therapeutic option for apoptosis-deficient solid tumors like colon cancer.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.3K